Dr. Bach is an Adjunct Professor in the Division of Infectious Diseases at the University of British Columbia in Vancouver, Canada. His research interests include understanding how pathogenic microorganisms successfully infect and multiply in humans, nanomedicine and antibody design. In his presentation, Dr. Bach discusses how MAP can survive in the macrophage and levels of antibodies found in Crohn’s patients vs. healthy control. Antibody levels are measured before and after traditional Crohn’s disease treatments are administered.
2017 MAP Conference | The Dark Art of MAP Culture
Dr. Bull is is a Senior Lecturer in Infectious Diseases and Associate Dean of the Biological Research Facility at St. George’s University of London. His presentation discusses his research on dormant forms of MAP and why cattle is the preferred host. He discusses factors which may activate MAP out of dormancy in vitro and what is known about the genetics and properties of human strains of MAP. Questions from the audience follow the presentation.
2017 MAP Conference | MAP Associated Crohn’s Disease and Treatment
Dr. Chamberlin is a gastroenterologist at the San Antonio Military Medical Center in Texas. In his talk, he presents evidence of healing in Crohn’s disease patients treated with antibiotics. He also reviews some of the literature on antibiotic treatment in Crohn’s disease and discusses the flawed Selby antibiotic trial. “Do antibiotics have a positive effect on Crohn’s disease? Absolutely.”
2017 MAP Conference | Diagnosis and Treatment of Human Infection by MAP
Dr. J. Todd Kuenstner details 5 case studies of related patients diagnosed with combinations of Crohn’s disease, Complex Regional Pain Syndrome, Raynaud’s phenomenon, Type 1 Diabetes and Lymphangiomatosis who also tested positive for MAP. Two cases were successfully treated with antibiotics and ultraviolet blood irradiation therapy. A Q&A session follows the presentation.
2017 MAP Conference | Is MAP the Trigger in the Crohn’s Spectrum?
Dr. Harry Oken is an Internal Medicine practitioner and a professor at the University of Maryland. Here, he presents one of his most challenging cases which had some of the hallmarks of Crohn’s disease, and was eventually resolved by a regimen of 5 antibiotics. The patient tested positive for MAP, and Dr. Oken hypothesizes that the MAP infection damaged the nerves in the ileum, leading to disease. This report suggests that MAP may be able to cause a variety of chronic illnesses apart from Crohn’s disease.